Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses

Journal of the Peripheral Nervous System

Volumn 20, Issue 3, 2015, Pages 277-288

  Draak, Thomas H P ^a   Vanhoutte, Els K ^a   Van Nes, Sonja I ^b   Gorson, Kenneth C ^c   Van Der Pol, W Ludo ^d   Notermans, Nicolette C ^d   Nobile Orazio, Eduardo ^e   Lewis, Richard A ^f   Léger, Jean Marc ^g   Van Den Bergh, Peter Y K ^h   Lauria, Giuseppe ⁱ   Bril, Vera ^j   Katzberg, Hans ^j   Lunn, Michael P T ^k   Pouget, Jean ^l   Van Der Kooi, Anneke J ^m   Hahn, Angelika F ⁿ   Van Den Berg, Leonard H ^d   Van Doorn, Pieter A ^b   Cornblath, David R ^o   Faber, Catharina G ^a   Merkies, Ingemar S J ^a,p   more..

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY OF MILAN   (Italy)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

ⁱ DEPARTMENT OF NEUROSURGERY   (Italy)

^j TORONTO GENERAL HOSPITAL   (Canada)

^k NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^l TIMONE HOSPITAL   (France)

^m ACADEMIC MEDICAL CENTER   (Netherlands)

ⁿ LONDON HEALTH SCIENCES CENTRE   (Canada)

^o JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p Department of Orthopaedic Surgery   (Netherlands)

more..

Author keywords

mISS; MRC; NIS; Rasch; responsiveness

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; INFLAMMATORY NEUROPATHY CAUSE AND TREATMENT SENSORY SCALE; INTER OBSERVER RELIABILITY; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH COUNCIL SUM SCORE; MONOCLONAL IMMUNOGLOBULINEMIA; NEUROLOGIC DISEASE ASSESSMENT; NEUROPATHY IMPAIRMENT SCALE; PARAMETERS; PRIORITY JOURNAL; PROPRIOCEPTION; RASCH ANALYSIS; RELIABILITY; REPRODUCIBILITY; RESPONSIVENESS; SENSATION; SOMATIC SENSE; STATISTICAL FIT; ADOLESCENT; COMPARATIVE STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; PARAPROTEINEMIA; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYRADICULONEUROPATHY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PARAPROTEINEMIAS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; REPRODUCIBILITY OF RESULTS; SENSATION; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84942588769     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/jns.12127     Document Type: Article

References (42)

1. Andrich D, Sheridan B, Luo G, (2010). Rasch Models for Measurement: RUMM2030. RUMM Laboratory, Perth.
2. Cohen J, (1988). Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates Inc, Hillsdale.
3. DeVellis RF, (2006). Classical test theory. Med Care 44: S50-S59.
4. Draak TH, Vanhoutte EK, van Nes SI, Gorson KC, Van der Pol WL, Notermans NC, Nobile-Orazio E, Leger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, Hahn AF, Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies IS, PeriNom SSG, (2014). Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness. Neurology 83: 2124-2132.
5. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton HI LJ, O'Brien PC, Litchy WJ, Windebank AJ, Smith BE, Low PA, Service FJ, Rizza RA, Zimmerman BR, (1991). The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 41: 799-807.
6. Dyck PJ, Karnes JL, O'Brien PC, Litchy WJ, Low PA, Melton LJ 3rd, (1992). The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology 42: 1164-1170.
7. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC, (1997). Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 49: 229-239.
8. Dyck PJ, Boes CJ, Mulder D, Millikan C, Windebank AJ, Espinosa R, (2005a). History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendation. J Peripher Nerv Syst 10: 158-173.
9. Dyck PJ, Hughes RAC, O'Brien PC, (2005b). Quantitating overall neuropathy symptoms, and outcomes. In: Peripheral Neuropathy., Dyck PJ, Thomas PK, (Eds). WB Saunders Company, Philadelphia.
10. EFNS/PNS (2010). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. J Peripher Nerv Syst 15: 185-195.
11. Fisher WP, (1992). Reliability statistics. Rasch Meas Transact 6: 238.
12. Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC, (2014). Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain 137: 33-43.
13. Gilman S, (2002). Joint position sense and vibration sense: anatomical organisation and assessment. J Neurol Neurosurg Psychiatry 73: 473-477.
14. Grimby G, Tennant A, Tesio L, (2012). The use of raw scores from ordinal scales: time to end malpractice? J Rehabil Med 44: 97-98.
15. Hermans MC, Merkies IS, Laberge L, Blom EW, Tennant A, Faber CG, (2013). Fatigue and daytime sleepiness scale in myotonic dystrophy type 1. Muscle Nerve 47: 89-95.
16. Herndon JE, Harrell FE Jr, (1990). The restricted cubic spline hazard model. Comm Statist Theory Meth 19: 639-663.
17. Hobart J, Cano S, (2009). Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess 13 iii, ix-x: 1-177.
18. Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Latov N, Merkies IS, van Doorn PA, (2008). Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol 7: 136-144.
19. Kazis LE, Anderson JJ, Meenan RF, (1989). Effect sizes for interpreting changes in health status. Med Care 27: S178-S189.
20. Kleyweg RP, van der Meche FG, Schmitz PI, (1991). Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 14: 1103-1109.
21. Lai J, Eton D, (2002). Clinically meaningful gaps. Rasch Meas Transact 14: 850.
22. Linacre JM, (1994). Sample size and item calibration stability. Rasch Meas Transact 7: 328.
23. Medical Research Council (1943). Aids to the Investigation of the Peripheral Nervous System. Her Majesty's Stationary Office, London.
24. Merbitz C, Morris J, Grip JC, (1989). Ordinal scales and foundations of misinference. Arch Phys Med Rehabil 70: 308-312.
25. Merkies IS, Lauria G, (2006). 131st ENMC International workshop: Selection of Outcome Measures for Peripheral Neuropathy Clinical Trials 10-12 December 2004, Naarden, The Netherlands. Neuromuscul Disord 16: 149-156.
26. Merkies IS, Schmitz PI, van der Meche FG, van Doorn PA, (2000). Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 54: 943-949.
27. Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA, Cause IN, Treatment Group (2003). Connecting impairment, disability, and handicap in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 74: 99-104.
28. Merkies IS, Hughes RA, Donofrio P, Bril V, Dalakas MC, Hanna K, Hartung HP, Latov N, van Doorn PA, Deng C, (2010). Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study. J Peripher Nerv Syst 15: 208-215.
29. Molenaar DS, de Haan R, Vermeulen M, (1995). Impairment, disability, or handicap in peripheral neuropathy: analysis of the use of outcome measures in clinical trials in patients with peripheral neuropathies. J Neurol Neurosurg Psychiatry 59: 165-169.
30. van Nes SI, Faber CG, Hamers RM, Harschnitz O, Bakkers M, Hermans MC, Meijer RJ, van Doorn PA, Merkies IS, (2008). Revising two-point discrimination assessment in normal aging and in patients with polyneuropathies. J Neurol Neurosurg Psychiatry 79: 832-834.
31. van Nes SI, Vanhoutte EK, van Doorn PA, Hermans M, Bakkers M, Kuitwaard K, Faber CG, Merkies IS, (2011). Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies. Neurology 76: 337-345.
32. van der Ploeg RJ, Oosterhuis HJ, (1991). The »make/break test» as a diagnostic tool in functional weakness. J Neurol Neurosurg Psychiatry 54: 248-251.
33. Rasch G, (1960). Probabilistic Models for Some Intelligence and Attainment Tests. Danmarks Paedagogiske Institut, Copenhagen.
34. Stillman BC, (2000). An investigation of the clinical assessment of joint position sense. PhD thesis, School of Physiotherapy, The University of Melbourne.
35. Streiner DL, Norman GR, (2008). Health Measurement Scales: A Practical Guide to their Development and Use. Oxford University Press, Oxford.
36. Stucki G, Daltroy L, Katz JN, Johannesson M, Liang MH, (1996). Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts. J Clin Epidemiol 49: 711-717.
37. Tennant A, Conaghan PG, (2007). The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 57: 1358-1362.
38. Vanhoutte EK, Faber CG, van Nes SI, Jacobs BC, van Doorn PA, van Koningsveld R, Cornblath DR, van der Kooi AJ, Cats EA, van den Berg LH, Notermans NC, van der Pol WL, Hermans MC, van der Beek NA, Gorson KC, Eurelings M, Engelsman J, Boot H, Meijer RJ, Lauria G, Tennant A, Merkies ISJ, (2012). Modifying the Medical Research Council grading system through Rasch analyses. Brain 135: 1639-1649.
39. Vanhoutte EK, Faber CG, Merkies IS, on behalf of the PeriNomS Study Group (2013). 196th ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8-10 February 2013, Naarden, The Netherlands. Neuromuscul Disord 23: 924-933.
40. ©). J Peripher Nerv Syst 20: 296-305.
41. Wright B, (2003). Rack and stack: time 1 vs time 2. Rasch Meas Transact 17: 905-906.
42. Wright BD, Stone MH, (1979). Best Test Design. Rasch Measurement. Chicago, Mesa Press.